Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug information and a revised version number, while significant details about FT500 and its clinical trial criteria have been removed.
    Difference
    40%
    Check dated 2025-04-16T02:59:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    1%
    Check dated 2025-04-09T00:43:48.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has updated its cancer-related content by adding information on Renal Cell Carcinoma and Pancreatic Cancer while removing references to Lymphosarcoma and Small Cell Lung Cancer. Additionally, the page has been revised from version 2.14.2 to 2.14.3.
    Difference
    1%
    Check dated 2025-04-01T19:04:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-03-25T13:15:37.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-03-18T05:33:37.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-03-11T00:38:35.000Z thumbnail image

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.